Adolescent brain and nicotine
Adolescence is a period of transition between childhood and adulthood that involves major changes in development in the physical, psychological, social and neurobiological domains. During this phase of life, multiple physical and emotional events occur throughout the body, markedly in the central nervous system, regulated by neurohormones, which are fundamental for human development, responsible for changes in thoughts, attitudes and behaviors that culminate in complete maturity for a laborious and reproductive life. Due to the lability of the neurological tissue in this period, external aggressions by means of chemical substances can cause serious and lasting effects. Nicotine is one of the substances considered legal and that more easily the adolescent comes into contact early, and can cause many harm to current and future health. This article presents some characteristics of the development of the adolescent's nervous system and the deleterious actions that can be caused by nicotine in its various forms of social presentation.
Keywords: Adolescence – nicotine – smoking – nicotine addiction
2. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 2007; 86:189-199.
3. Leshem R. Brain development, impulsivity, risky decision making, and cognitive control: integrating cognitive and socioemotional process during adolescence - an introduction to the special issue. Develop Neuropsychol 2016; 41:1-5.
4. Bernheim A, Halfon O, Boutrel B. Controversies about the enhanced vulnerability of the adolescent brain to develop addiction. Front Pharmacol 2013; 4:118:121.
5. Yuan M, Cross SJ, Loughlin SE, Leslie FM. Nicotine and the adolescent brain. J Physiol 2015; 16:3397–3412.
6. Siqueira LM. Nicotine and tobacco as substances of abuse in children and adolescents. Pediatrics. 2017; 139:1-15.
7. Kalkhoran S, Benowitz NL, Rigotti NA. Prevention and treatment of tobacco use: JACC health promotion series. J Am Coll Cardiol 2018; 72:1030-1045.
8. Sieber M. Neuroprotective properties of nicotine. Curr Med Chem 2012; 19:292-297.
9. Zarrindasta M, Khakpai F. The modulatory role of nicotine on cognitive and non-cognitive functions. Brain Research 2019; 1710:92-101.
10. Baraona LK, Lovelace D, Daniels JL, McDaniel L. Tobacco harms, nicotine pharmacology, and pharmacologic tobacco cessation interventions for women. J Midwifery Womens Health 2017; 62:253-269.
11. Valentine G, Sofuoglu M. Cognitive effects of nicotine: recent progress. Cur Neuropharmacol 2018; 16:403-414.
12. Alkam T, Nabeshima T. Molecular mechanisms for nicotine intoxication. Neuroch Int 2019; 125:117-126.
13. Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: a review. Int J Toxicol 2016; 35:179-185.
14. Ginzel KH, Maritz GS, Marks DF, Neuberger M, Pauly JR, Polito JR et al. Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 2007; 12:215-224.
15. Abreu-Villaça Y, Seidler FJ, Tate CA, Slotkin TA. Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. Brain Res 2003; 979:114-128.
16. Ferrea S, Winterer G. Neuroprotective and neurotoxic effects of nicotine. Pharmacopsych 2009; 42:255-265.
17. Franken RA, Nitrini G, Franken M, Fonseca AJ, Leite JCT. Nicotine. Actions and interactions. Arq Bras Cardiol 1996; 66:371-373.
18. Grundey J, Barlay J, Batsikadze G, Kuo MF, Paulus W, Nitsche M. Nicotine modulates human brain plasticity via calcium-dependent mechanisms. J Physiol 2018; 596:5429-5441.
19. Silva MTB, Araujo FLO, Felix FHC, Simão AFL, Lobato RFG, Sousa FCF et al. Alcohol and nicotine: mechanisms of dependence. Rev Neurocienc 2010; 18:531-537.
20. Planeta CS, Cruz FC. Neurophysiological basis of tobacco dependence. Arch Clin Psych 2005; 32:25125-8.
21. Dao JM, McQuown SC, Loughlin SE, Belluzzi JD, Leslie FM. Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism. Neuropsychopharmacol 2011; 36:1319–1331.
22. Ziedonis D, Das S, Larkin C. Tobacco use disorder and treatment: new challenges and opportunities. Dialogues Clin Neurosci. 2017; 19:271–280.
23. Mahase E. Half of smokers think nicotine vaping products are at least as harmful as smoking. BMJ 2020; 368:1.
24. Salmanzadeh H, Ahmadi-Soleimani SM, Pachenari N, Azadi M, Halliwell RF, Rubino T et al. Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function. Brain Res Bull 2020; 156:105-117.
25. Paus T. Growth of white matter in the adolescent brain: Myelin or axon? Brain Cogn 2010; 72:26–35.
26. England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 2015; 49:286-293.
27. Holliday ED, Nucero P, Kutlu MG, Oliver C, Connelly KL, Gould TJ et al. Long-term effects of chronic nicotine on emotional and cognitive behaviors and hippocampus cell morphology in mice: comparisons of adult and adolescent nicotine exposure. Eur J Neurosci 2016; 44:2818–2828.
28. Ehlinger, D.G., Bergstrom, H.C., Burke, J.C., Fernandez, G.M., McDonald, C.G., Smith, R.F. Adolescent nicotine-induced dendrite remodeling in the nucleus accumbens is rapid, persistent, and D1-dopamine receptor dependent. Brain Struct. Funct. 2016; 221:133–145.
29. Portugal GS, Wilkinson DS, Turne, JR, Blendy JA, Gould TJ. Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiol Learn Mem 2012; 97:482–494.
30. Renaud SM, Pickens LRG, Fountain SB. Paradoxical effects of injection stress and nicotine exposure experienced during adolescence on learning in a serial multiple choice (SMC) task in adult female rats. Neurotoxicol Teratol 2015; 48:40–48.
31. Conti AA, McLean L, Tolomeo S, Steele JD, Baldacchino A. Chronic tobacco smoking and neuropsychological impairments: A systematic review and meta-analysis. Neurosci Biobehav Rev 2019; 96:143-154.
32. Kutlu MG, Gould TJ. Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory. Physiol Behav 2016; 155:162-171.
33. Zeid D, Kutlu MG, Gould TJ. Differential effects of nicotine exposure on the hippocampus across lifespan. Cur Neuropharmacol 2018; 16:388-402.
34. Kendler KS, Myers J, Damaj MI, Chen X. Early smoking onset and risk for subsequent nicotine dependence: a monozygotic co-twin control study. Am J Psychiatry 2014; 170:408–413.
35. Shao XM, Fang ZT. Severe acute toxicity of inhaled nicotine and e-cigarettes. Chest 2020; 157:506-508.
36. Prokhorov AV, Calabro KS, Tamí-Maury I. Nicotine and tobacco use prevention among youth and families. Sem Oncol Nurs 2016; 32:197-205.
37. Cavallo DA, Krishnan-Sarin S. Nicotine use disorders in adolescents. Pediatr Clin N Am 2019; 66:1053–1062.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).